Can Fite Biopharma
CANF
#9760
Rank
NZ$21.78 M
Marketcap
$3.37
Share price
-1.99%
Change (1 day)
-4.59%
Change (1 year)

Market capitalization of Can Fite Biopharma (CANF)

Market cap: NZ$21.78 Million

As of November 2024 Can Fite Biopharma has a market cap of NZ$21.78 Million. This makes Can Fite Biopharma the world's 9760th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Can Fite Biopharma from 2012 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$21.78 M-1.81%
2023NZ$22.18 M-22.82%
2022NZ$28.74 M-39.28%
2021NZ$47.34 M19.51%
2020NZ$39.61 M104.72%
2019NZ$19.34 M-47.87%
2018NZ$37.11 M6.98%
2017NZ$34.69 M-27.12%
2016NZ$47.6 M-20.07%
2015NZ$59.55 M23.39%
2014NZ$48.26 M-11.95%
2013NZ$54.81 M85.06%
2012NZ$29.62 M

End of Day market cap according to different sources

On Nov 21st, 2024 the market cap of Can Fite Biopharma was reported to be:

NZ$18.97 Million
by Nasdaq info icon info icon
NZ$22.13 Million
by CompaniesMarketCap info icon info icon